Matches in SemOpenAlex for { <https://semopenalex.org/work/W2418213118> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2418213118 endingPage "72" @default.
- W2418213118 startingPage "166" @default.
- W2418213118 abstract "The role of erythropoietin (EPO) plus granulocyte-colony stimulating factor (G-CSF) combination in hemopoietic recovery was studied in patients with high-risk breast carcinoma and compared to a control group of previously treated identical patients who were not given EPO plus G-CSF. Eleven consecutive patients admitted to this study had Stage III or IV breast cancer. They received 6 cycles of intensive chemotherapy (epirubicin 150 mg/m2 and cyclophosphamide 1300 mg/m2). The 1st cycle served for mobilization of peripheral blood progenitor cells (PBPC). At its end leukaphereses collections of PBPC were performed to be used as hematologic support (PBPCT) in the 5 remaining cycles. The administration of EPO plus G-CSF was started when leukocyte (WBC) count in peripheral blood dropped below 1 x 10(9)/l and hemoglobin (Hb) level fell below 100 g/l. The treatment was stopped when leukocyte count rose to 5 x 10(9)/l and Hb to 130 g/l. EPO plus G-CSF combination after PBPCT produced significant effects in terms of hemopoietic recovery, clinical benefit and supportive care requirements when compared with 12 historic control patients: Periods of leukopenia were shorter which resulted in reduced risk of infectious complications. The grades of leukopenia in the study and control groups were as follows: grade 4 (36 vs. 18%), grade 3 (57 vs. 30%), grade 2 (7 vs. 13%) respectively. Significantly shorter was the time of PLT recovery < 50 x 10(9)/l (p < 0.001). The grades of thrombocytopenia were: grade 4 (29 vs. 11%), grade 3 (21 vs. 12%), grade 2 (25 vs. 36%) respectively. The number of necessary transfusions was significantly reduced as well as the length of hospital stay (p < 0.001). In conclusion, our results obtained in this study confirm that combination of EPO plus G-CSF not only increases the rate of hemopoietic recovery, reduces the number of necessary red blood cell and platelet transfusions but, at the same time, simplifies the clinical management and is more tolerable for the patients." @default.
- W2418213118 created "2016-06-24" @default.
- W2418213118 creator A5001832911 @default.
- W2418213118 creator A5060375720 @default.
- W2418213118 creator A5063954305 @default.
- W2418213118 creator A5067942553 @default.
- W2418213118 creator A5078226465 @default.
- W2418213118 creator A5085666836 @default.
- W2418213118 date "1999-01-01" @default.
- W2418213118 modified "2023-09-30" @default.
- W2418213118 title "The increase of the rate of hemopoietic recovery and clinical benefit of the erythropoietin (EPO) and granulocyte colony-stimulating factor (G-CSF) with peripheral blood progenitor cells (PBPC) after intensive cyclic chemotherapy in high-risk breast cancer patients." @default.
- W2418213118 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10613592" @default.
- W2418213118 hasPublicationYear "1999" @default.
- W2418213118 type Work @default.
- W2418213118 sameAs 2418213118 @default.
- W2418213118 citedByCount "6" @default.
- W2418213118 crossrefType "journal-article" @default.
- W2418213118 hasAuthorship W2418213118A5001832911 @default.
- W2418213118 hasAuthorship W2418213118A5060375720 @default.
- W2418213118 hasAuthorship W2418213118A5063954305 @default.
- W2418213118 hasAuthorship W2418213118A5067942553 @default.
- W2418213118 hasAuthorship W2418213118A5078226465 @default.
- W2418213118 hasAuthorship W2418213118A5085666836 @default.
- W2418213118 hasConcept C10205521 @default.
- W2418213118 hasConcept C109159458 @default.
- W2418213118 hasConcept C126322002 @default.
- W2418213118 hasConcept C141071460 @default.
- W2418213118 hasConcept C2776694085 @default.
- W2418213118 hasConcept C2776755627 @default.
- W2418213118 hasConcept C2777371436 @default.
- W2418213118 hasConcept C2777767877 @default.
- W2418213118 hasConcept C2777983669 @default.
- W2418213118 hasConcept C2778534260 @default.
- W2418213118 hasConcept C2780835546 @default.
- W2418213118 hasConcept C2780873365 @default.
- W2418213118 hasConcept C28328180 @default.
- W2418213118 hasConcept C54355233 @default.
- W2418213118 hasConcept C71924100 @default.
- W2418213118 hasConcept C86803240 @default.
- W2418213118 hasConcept C90924648 @default.
- W2418213118 hasConceptScore W2418213118C10205521 @default.
- W2418213118 hasConceptScore W2418213118C109159458 @default.
- W2418213118 hasConceptScore W2418213118C126322002 @default.
- W2418213118 hasConceptScore W2418213118C141071460 @default.
- W2418213118 hasConceptScore W2418213118C2776694085 @default.
- W2418213118 hasConceptScore W2418213118C2776755627 @default.
- W2418213118 hasConceptScore W2418213118C2777371436 @default.
- W2418213118 hasConceptScore W2418213118C2777767877 @default.
- W2418213118 hasConceptScore W2418213118C2777983669 @default.
- W2418213118 hasConceptScore W2418213118C2778534260 @default.
- W2418213118 hasConceptScore W2418213118C2780835546 @default.
- W2418213118 hasConceptScore W2418213118C2780873365 @default.
- W2418213118 hasConceptScore W2418213118C28328180 @default.
- W2418213118 hasConceptScore W2418213118C54355233 @default.
- W2418213118 hasConceptScore W2418213118C71924100 @default.
- W2418213118 hasConceptScore W2418213118C86803240 @default.
- W2418213118 hasConceptScore W2418213118C90924648 @default.
- W2418213118 hasIssue "3" @default.
- W2418213118 hasLocation W24182131181 @default.
- W2418213118 hasOpenAccess W2418213118 @default.
- W2418213118 hasPrimaryLocation W24182131181 @default.
- W2418213118 hasRelatedWork W117717171 @default.
- W2418213118 hasRelatedWork W1939178279 @default.
- W2418213118 hasRelatedWork W1975045405 @default.
- W2418213118 hasRelatedWork W2008675714 @default.
- W2418213118 hasRelatedWork W2138917119 @default.
- W2418213118 hasRelatedWork W2405162293 @default.
- W2418213118 hasRelatedWork W2418213118 @default.
- W2418213118 hasRelatedWork W2432246077 @default.
- W2418213118 hasRelatedWork W254308104 @default.
- W2418213118 hasRelatedWork W3023484944 @default.
- W2418213118 hasVolume "46" @default.
- W2418213118 isParatext "false" @default.
- W2418213118 isRetracted "false" @default.
- W2418213118 magId "2418213118" @default.
- W2418213118 workType "article" @default.